Journal article
Development of an Improved T-cell assay to assess the intrinsic immunogenicity of haptenic compounds
Toxicological Sciences, Vol.175(2), pp.266-278
2020
Abstract
The prediction of drug hypersensitivity is difficult due to the lack of appropriate models and known risk factors. In vitro naïve T-cell priming assays that assess immunogenicity have been developed. However, their application is limited due requirements for 2 batches of autologous dendritic cells (DC) and inconsistent results; a consequence of single well readouts when exploring reactions where compound-specific T-cell frequency is undefined. Hence, we aimed to develop an improved, but simplified assay, termed the T-cell multiple well assay (T-MWA), that permits assessment of drug-specific activation of naïve T cells, alongside analysis of the strength of the induced response and the number of cultures that respond. DC naïve T-cell coculture, depleted of regulatory T cells (Tregs), was conducted in up to 48 wells for 2 weeks with model haptens (nitroso sulfamethoxazole [SMX-NO], Bandrowski’s base [BB], or piperacillin [PIP]). Cultures were rechallenged with hapten and T-cell proliferation was measured using [3H]-thymidine incorporation. Priming of naïve T cells was observed with SMX-NO, with no requirement for DC during restimulation. Greater than 65% of cultures were activated with SMX-NO; with 8.0%, 30.8%, and 27.2% characterized as weak (stimulation index [SI] =1.5–1.9), moderate (SI = 2–3.9), and strong responses (SI > 4), respectively. The number of responding cultures and strength of the response was reproducible when separate blood donations were compared. Coinhibitory checkpoint blockade increased the strength of the proliferative response, but not the number of responding cultures. Moderate to strong priming responses were detected with BB, whereas PIP stimulated only a small number of cultures to proliferate weakly. In drug-responsive cultures inducible CD4+CD25+FoxP3+CD127low Tregs were also identified. To conclude, the T-MWA offers improvements over existing assays and with development it could be used to study multiple HLA-typed donors in a single plate format.
Details
- Title
- Development of an Improved T-cell assay to assess the intrinsic immunogenicity of haptenic compounds
- Authors/Creators
- D.J. Naisbitt (Author/Creator) - University of LiverpoolB.K. Park (Author/Creator) - University of LiverpoolM.Z. Sakatis (Author/Creator) - GlaxoSmithKline (United Kingdom)A. Hillegas (Author/Creator) - GlaxoSmithKline (United States)A. Gibson (Author/Creator) - University of LiverpoolL. Faulkner (Author/Creator) - University of LiverpoolA. Lister (Author/Creator) - University of LiverpoolJ. Watkinson (Author/Creator) - University of LiverpoolM.O. Ogese (Author/Creator) - University of Liverpool
- Publication Details
- Toxicological Sciences, Vol.175(2), pp.266-278
- Publisher
- Oxford Academic
- Identifiers
- 991005546333507891
- Copyright
- © 2020 The Authors
- Murdoch Affiliation
- Institute for Immunology and Infectious Diseases
- Language
- English
- Resource Type
- Journal article
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites
Metrics
40 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Industry collaboration
- Domestic collaboration
- International collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.265 Dermatology - Skin Allergies
- 1.265.1140 Drug Hypersensitivity
- Web Of Science research areas
- Toxicology
- ESI research areas
- Pharmacology & Toxicology